Wade Thompson, Carina Lundby, Adam Bleik, Harman Waring, Jung Ah Hong, Chris Xi, Carmel Hughes, Douglas M Salzwedel, Emily G McDonald, Jennifer Pruskowski, Sion Scott, Anne Spinewine, Jean S Kutner, Trine Graabæk, Shahrzad Elmi, Frank Moriarty
BACKGROUND: Quality of life (QoL) is an important outcome to capture in clinical trials evaluating deprescribing interventions. OBJECTIVE: We aimed to conduct a scoping review to examine how QoL has been measured in deprescribing trials among older people and identify potentially relevant QoL scales, to better inform QoL measurement in future deprescribing trials. METHODS: We searched MEDLINE, Embase, PsycINFO, the Cochrane Central Register of Controlled Trials, Google Scholar, Epistemonikos, ClinicalTrials...
May 6, 2024: Drugs & Aging